Skip to main content
SpringerLink
Log in
Book cover

Behavioral Medicine with the Developmentally Disabled pp 121–136Cite as

Behavioral Assessment Technology for Pharmacotherapy in Developmental Disabilities

  • Chapter

  • 27 Accesses

Abstract

The burgeoning field of behavioral assessment in behavioral medicine and in developmental disabilities requires that, for a meaningful discussion within a brief chapter, the topic must be restricted even further. We have chosen behavioral assessment of pharmacotherapy with persons who have developmental disabilities because it is currently a very visible and controversial topic, with a rich research literature. The plan of this paper is to review the necessary behavioral and pharmacological issues that need to be considered when evaluating or conducting research in this area. It is not an exhaustive review. More complete treatment of our approach to behavioral assessment in mental retardation can be found in Rojahn and Schroeder (1983) and to behavioral pharmacotherapy with developmental disabilities in Schroeder, Lewis, and Lipton (1983). We will recommend several other current topical reviews as the various topics are treated. Five textbooks are recommended: Gadow and Poling (1988), Gadow (1986), Gualtieri, Schroeder, & Keppel (1987); Hersen (1986), and Werry (1978).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aman, M. G. (1984). Drugs and learning in mentally retarded persons. In G. D. Burrows & J. S. Werry (Eds.), Advances in human psychopharmacology (Vol 3, pp. 121–163 ). Greenwich, CT: J AI.

    Google Scholar 

  • Aman, M. G., & Singh, N. N. (1986). A critical appraisal of recent drug research in mental retardation: The Coldwater studies. Journal of Mental Deficiency Research, 30, 203–216.

    PubMed  Google Scholar 

  • Aman, M. G., & White, A. J. (1986). Measures of drug change in mental retardation. In K. D. Gadow (Ed.), Advances in learning and behavioral disabilities (Vol. 5, pp. 157–202 ). Greenwich, CT: J AI.

    Google Scholar 

  • Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The Aberrant Behavior Checklist: A behavior rating scale for measurement of treatment effects. American Journal of Mental Deficiency, 89, 485–491.

    PubMed  Google Scholar 

  • Aman, M. G., Teehan, C. J., White, A. J., Turbott, S. H., & Vaithianathan, C. (1986). Haloperidol treatment with chronically medicated residents: Dose effects on clinical behavior and reinforcement contingencies. Manuscript submitted for publication.

    Google Scholar 

  • Baumeister, A. A., & Rollings, P. (1976). Self-injurious behavior. In N. R. Ellis (Ed.), International review of research in mental retardation (Vol. 9, pp. 1–33 ) New York: Academic.

    Google Scholar 

  • Baumeister, A. A., Frye, G. R., & Schroeder, S. R. (1984). Neurochemical correlates of self-injurious behavior. In J. A. Mulick & B. L. Mallory (Eds.), Transitions in mental retardation: Advocacy, technology and science. Norwood, NJ: Ablex.

    Google Scholar 

  • Breese, G. R., Baumeister, A. A., McCowan, T. J., Emerick, S., Frye, G. D., & Mueller, R. A. (1984). Neonatal-6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacology Biochemistry and Behavior, 21, 459–461.

    Article  Google Scholar 

  • Breese, G. R., Baumeister, A. A., McCown, T. J., Emerick, S., Frye, G. D., Crotty, K., & Mueller, R. A. (1985). Behavioral differences between neonatal- and adult-6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. Journal of Pharmacology and Experimental Therapeutics, 234, 447–455.

    PubMed  Google Scholar 

  • Briant, R. H. (1978). An introduction to clinical pharmacology. In J. S. Werry (Ed.), Pediatric psychopharmacology (pp. 3–28 ). New York: Brunner/Mazel, 1978.

    Google Scholar 

  • Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C., & Sachar, E. J. (1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17, 640–655.

    Article  PubMed  Google Scholar 

  • Campbell, M., Anderson, L. T., Small, A. M., Perry, R., Green, W. H., & Caplan, R. (1982). The effects of haloperidol on learning and behavior in autistic children. Journal of Autism and Developmental Disorders, 12, 167–176.

    Article  PubMed  Google Scholar 

  • Cataldo, M. F., & Harris, J. (1982). The biological basis for self-injury in the mentally retarded. Analysis and Intervention in Developmental Disabilities, 2, 21–39.

    Article  Google Scholar 

  • Chassan, J. B. (1979). Research design in clinical psychology and psychiatry. New York: Halstead.

    Google Scholar 

  • Christensen, D. E. (1975). Effects of combining methylphenidate and a classroom token system in modifying hyperactive behavior. American Journal of Mental Deficiency, 80, 266–276.

    PubMed  Google Scholar 

  • Conners, C. K. (1969). A teacher rating scale for use in drug studies with children. American Journal of Psychiatry, 126, 152–156.

    Google Scholar 

  • Eaton, L. F., & Menolascino, F. J. (1982). Psychiatric disorders in the mentally retarded: Types, problems, and challenges. American Journal of Psychiatry, 139, 1297–1303.

    PubMed  Google Scholar 

  • Gadow, K. D. (1982). Drug use in the public schools. In S. Breuning & A. Poling (Eds.), Drugs and mental retardation (pp. 330–350 ). Springfield, IL: Charles C Thomas.

    Google Scholar 

  • Gadow, K. D. (1986). Children on medication (Vols. 1 and 2 ). Waltham, MA: Little, Brown.

    Google Scholar 

  • Gadow, K. D., & Poling, A. G. (1988). Pharmacotherapy and mental retardation. Boston: Little, Brown.

    Google Scholar 

  • Gittleman-Klein, R., & Klein, D. (1976). Methylphenidate effects in learning disabilities: Psychometric changes. Archives of General Psychiatry, 33, 655–664.

    PubMed  Google Scholar 

  • Goldstein, M., Anderson, L. T., Reuben, R., & Dancis, J. (1985). Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation. The Lancet, February 9, 338–339.

    Article  Google Scholar 

  • Gualtieri, C. T., & Hawk, B. (1980). Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth. Applied Research in Mental Retardation, 1, 55–69.

    Article  PubMed  Google Scholar 

  • Gualtieri, C. T., Breese, G. R., Schroeder, S. R., & Keppel, J. M. ( 1986, March). Rational pharmacotherapy for self-injurious behavior: Testing the D-l model Paper presented at the 19th Gatlinburg Conference on Research and Theory in Mental Retardation and Developmental Disabilities. Gatlinburg, Tennessee.

    Google Scholar 

  • Gualtieri, C. T., Schroeder, S. R., & Keppel, J. M. (In press). Psychiatric treatment for mentally retarded people. Washington, DC: American Psychiatric Association Monographs.

    Google Scholar 

  • Helper, M., Wilcott, R., & Garfield, S. (1963). Effects of chlorpromazine on learning and related processes in emotionally disturbed children. Journal of Consulting Psychology, 27, 1–9.

    Article  Google Scholar 

  • Hersen, M. H. (1986). Pharmacological and behavioral treatment. New York: Wiley.

    Google Scholar 

  • Hicks, R. E., Gualtieri, C. T., Mayo, J. P., Schroeder, S. R., & Lipton, M. H. (1984). Methylphenidate and homeostasis: Drug effects on the cognitive performance of hyperactive children. In L. M. Bloomingdale (Ed.), Attention deficit disorder (Vol. 1, pp. 131–142 ). New York: Spectrum.

    Google Scholar 

  • Hollis, J. H. (1968). Chlorpromazine: Direct measurement of differential behavioral effect. Science, 159, 1487–1489.

    Article  PubMed  Google Scholar 

  • Johnston, J. M., Wallen, A., Partin, J., Neu, E., Cade, R. F., Stein, G. H., Goldstein, M. K., Pennypacker, H. S., & Gfeller, E. (1983). Human operant laboratory measurement of the effects of chemical variables. Psychological Record, 33, 457–472.

    Google Scholar 

  • Kagan, J. (1966). Reflection-impulsivity: The generality and dynamics of conceptual tempo. Journal of Abnormal Psychology, 71, 17–24.

    Article  PubMed  Google Scholar 

  • Kazdin, A. (1977). Artifact, bias, and complexity of assessment: The ABC’s of reliability. Journal of Applied Behavior Analysis, 10, 141–150.

    Article  PubMed  Google Scholar 

  • Kinsbourne, M. (1985). Base-state dependency of stimulant effects on the cognitive performance of hyperactive children. In L. M. Bloomingdale (Ed.), Attention deficit disorder (Vol. 1, pp. 143–154 ). New York: Spectrum.

    Google Scholar 

  • Lesch, M., & Nyhan, W. L. (1964). A familial disorder of uric acid metabolism and central nervous system function. American Journal of Medicine, 36, 561–570.

    Article  PubMed  Google Scholar 

  • Lewis, M. H., Steer, R. A., Favell, J., McGimsey, J., Clontz, L., Trivette, C., Jodry, W., Schroeder, S. R., Kanoy, R. C., & Mailman, R. B. (1986). Thioridazine and metabolite blood levels and effects on human stereotyped behavior. Psychopharmacology Bulletin, 22, 1040–1044.

    Google Scholar 

  • Lloyd, K. G., Hornykiewicz, O., Davidson, L., Shannak, K., Farley, I., Goldstein, M., Shibuya, M., Kelley, W., & Fox, I. H. (1981). Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. New England Journal of Medicine, 305, 1106–1111.

    Article  PubMed  Google Scholar 

  • Lovaas, O. I., Freitag, G., Gold, V., & Kassorla, I. (1965). Experimental studies in childhood schizophrenia: Analysis of self-destructive behavior. Journal of Experimental Child Psychology, 2, 67–84.

    Article  Google Scholar 

  • Marholin, D., Touchette, P., & Stewart, R. M. (1979). Withdrawal of chronic chlorpromazine medication: An experimental analysis. Journal of Applied Behavior Analysis, 12, 159–171.

    Article  PubMed  Google Scholar 

  • Nyhan, W. L., Johnson, H., Kaufman, I., Jones, K. (1980). Serotonergic approaches to modification of behavior in the Lesch-Nyhan syndrome. Applied Research in Mental Retardation, 1, 25–40.

    Article  PubMed  Google Scholar 

  • Pardo, J. V., Creese, I., Burt, D. R., & Snyder, S. H. (1977). Ontogenesis of dopamine receptor binding in the corpus striatum of the rat. Brain Research, 125, 367–382.

    Article  Google Scholar 

  • Pfadt, A., & Tryon, W. W. (1983). Issues in the selection and use of mechanical transducers to directly measure motor activity in clinical settings. Applied Research in Mental Retardation, 4, 251–270.

    Article  PubMed  Google Scholar 

  • Poling, A., & Breuning, S. E. (1983). Effects of methylphenidate on the fixed-ratio performance of mentally retarded children. Pharmacology, Biochemistry, and Behavior, 28, 541–544.

    Article  Google Scholar 

  • Poling, A., Picker, M., & Hall-Johnson, E. (1983). Human behavioral pharmacology. The Psychological Record, 33, 437–493.

    Google Scholar 

  • Rapoport, J. L., & Conners, K. C. (Eds.). (1985). Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin, 21(4), 713–1124.

    Google Scholar 

  • Reatig, N. (Ed.). (1985). Pharmacotherapy and mental retardation workshop. Psychopharmacology Bulletin, 21(2), 258–333.

    Google Scholar 

  • Rie, D. R., & Rie, H. E. (1977). Recall, retention, and Ritalin. Journal of Clinical and Consulting Psychology, 47, 967–972.

    Article  Google Scholar 

  • Rojahn, J., & Schroeder, S. R. (1983). Behavioral assessment. In J. L. Matson & J. A. Mulick (Eds.), Handbook of mental retardation (pp. 227–244 ). New York: Pergamon.

    Google Scholar 

  • Schroeder, S. R. (1984). Neurochemical and behavioral interactions with stereotyped self-injurious behavior. In J. C. Griffin, M. T. Stark, D. E. Williams, B. K. Altmeyer, & H. K. Griffin (Eds.), Advances in the treatment of SIB (pp. 61–78 ). Austin: Texas Planning Council for Developmental Disabilities.

    Google Scholar 

  • Schroeder, S. R. (1985). Issues and future directions of pharmacotherapy in mental retardation. Psychopharmacology Bulletin, 21 (2), 323–326.

    PubMed  Google Scholar 

  • Schroeder, S. R., & Gualtieri, C. T. (1985). Behavioral interactions induced by chronic neuroleptic therapy with persons with mental retardation, Psychopharmacology Bulletin, 21, 323–326.

    PubMed  Google Scholar 

  • Schroeder, S. R., Lewis, M. H., & Lipton, M. A. (1983). Interactions of pharmacotherapy and behavior therapy among children with learning and behavioral disorders. In K. Gadow & I. Bailer (Eds.), Advances in learning and behavioral disabilities (Vol. 2, pp. 179–225 ). Greenwich, CT: JAI.

    Google Scholar 

  • Seeman, P. (1981). Brain dopamine receptors. Pharmacological Reviews, 32, 229–313.

    Google Scholar 

  • Sovner, R., & Hurley, A. D. (1983). Do the mentally retarded suffer from affective illness? Archives of General Psychiatry, 40, 61–67.

    PubMed  Google Scholar 

  • Sprague, R., & Sleator, E. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274–1276.

    Article  PubMed  Google Scholar 

  • Sprague, R. L., & Werry, J. S. (1971). Methodology of psychopharmacology studies with the retarded. In N. R. Ellis (Ed.), International review of research in mental retardation (Vol. 5, pp. 147–219 ). New York: Academic.

    Google Scholar 

  • Sykes, D., Douglas, V., & Morgenstern, G. (1972). The effect of methylphenidate (Ritalin) or sustained attention in hyperactive children. Psychopharmacologia, 25, 262–274.

    Article  PubMed  Google Scholar 

  • Walker, M. K. (1982). Stimulant drugs. In S. E. Breuning & A. D. Poling (Eds.), Drugs in mental retardation (pp. 235–267 ). Springfield, IL: Charles C Thomas.

    Google Scholar 

  • Walls, R. T., Werner, T. J. Bacon, A., & Zane, T. (1977). Behavior checklists. In J. D. Cone & R. P. Hawkins, (Eds.), Behavioral assessment: New directions in clinical psychology (pp. 77–146 ). New York: Brunner/Mazel.

    Google Scholar 

  • Werry, J. S. (Ed.). (1978). Pediatric psychopharmacology. New York: Brunner/Mazel.

    Google Scholar 

  • Whalen, C. K., & Henker, B. (1976). Psychostimulants and children: A review and analysis. Psychological Bulletin, 83, 1113–1130.

    Article  PubMed  Google Scholar 

  • White, T. J., & Aman, M. G. (1985). Pimozide treatment in disruptive severely retarded patients. Australian-New Zealand Journal of Psychiatry, 19, 92–94.

    Article  Google Scholar 

  • Wysocki, T., Fuqua, W., Davis, V., & Breuning, S. E. (1981). Effects of thioridazine (Mellaril) on titrating delayed matching-to-sample performance of mentally retarded adults. American Journal of Mental Deficiency, 85, 539–547.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Nisonger Center, Ohio State University, Columbus, Ohio, 43210, USA

    Stephen R. Schroeder

Authors
  1. Stephen R. Schroeder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Children’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Dennis C. Russo

  2. Kennedy Memorial Hospital for Children, Brighton, Massachusetts, USA

    Jurgen H. Kedesdy

  3. Harvard Medical School, Boston, Massachusetts, USA

    Jurgen H. Kedesdy

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Schroeder, S.R. (1988). Behavioral Assessment Technology for Pharmacotherapy in Developmental Disabilities. In: Russo, D.C., Kedesdy, J.H. (eds) Behavioral Medicine with the Developmentally Disabled. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0999-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0999-4_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8285-3

  • Online ISBN: 978-1-4613-0999-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation